|
|
|
IMRIS. (NSDQ: IMRS TSX: IM) added Apr 11, 2011 IMRIS provides fully integrated image guided therapy solutions that deliver timely information to clinicians for use during surgical or interventional procedures. Our solutions incorporate magnetic resonance imaging and fluoroscopy into multi purpose surgical suites for specific medical applications. Our products are sold globally to hospitals that deliver clinical services to patients in the neurosurgical, interventional neurovascular and cardiovascular markets. All IMRIS systems are designed to address important needs of patients, clinicians and hospitals: Patients: The patient does not need to be moved for imaging during the course of a surgical or interventional procedure with IMRIS systems. This saves time and avoids potential safety risks associated with moving the patient. Clinicians: IMRIS systems are designed to enhance the workflow of the clinical team. High resolution imaging information is available rapidly and presented in a manner designed to enhance clinician efficiency and effectiveness. In addition, since the patient is not moved for imaging, the patient can be maintained in the optimal position and clinicians are afforded unrestricted access to the patient. Hospitals: The IMRIS suite design permits greater utilization of the MR equipment by allowing the MR scanner to be shared by one or more clinical suites and an adjacent diagnostic room. Our mission is to provide image guided therapy solutions that enhance the quality of clinical procedures and improve outcomes for patients. Through our ongoing investment in research and development we are committed to broadening our product portfolio with solutions to address additional medical applications.
Recent News: IMRIS reports third quarter 2011 financial results IMRIS and MDA Advancing Image Guided Surgical Robotics Program Leading Academic Medical Center Purchases IMRISneuro and iCT Systems IMRIS Sells IMRISneuro and iCT Systems to a Single U.S. Customer Imris Reports First Quarter 2011 Results University of Utah Hospital Purchases IMRISNV IMRISneuro Purchased by University Hospital Tübingen Imris Reports Strong Fourth Quarter 2010 Results Douglas Miehm.....RBC Capital Markets….Nov 15, 2011 Maintained SECTOR PERFORM Target reduced to $3.00 from $4.50US IMRS Price day before:$3.20Finish day posting$2.59Current $2.59US ------Oct 31, 2011----- Downgraded to SECTOR PERFORM from OUTPERFORM IMRS Price day before:$3.45Finish day posting$3.44Current $2.59US -------Aug 10, 2011------- Target reduced to $6.50 from $7.00C IMRS Price day before:$4.40Finish day posting$3.59Current $2.59US ------Aug 08, 2011------- Target reduced to $7.00 from $8.00C IMRS Price day before:$5.52Finish day posting$4.63Current $2.59US -----Nov 05, 2010--- Target raised to $8.00 from $7.00 (Target Hit Jan 20, 2011) IMRS Price day before:$5.87Finish day posting$6.10Current $2.59US ****************** Jason R. Mills .....Canaccord/Genuity…..Nov 15, 2011 Maintained BUY Target reduced to $4.50 from $5.25US IMRS Price day before:$3.20Finish day posting$2.59Current $2.59US ------Aug 10, 2011-------- Maintained BUY Target reduced to $5.25 from $7.00US IMRS Price day before:$3.16Finish day posting$3.29Current $2.59US -----Aug 10, 2011------ Maintained BUY Target reduced to $7.00 from $10.50US IMRS Price day before:$4.40Finish day posting$3.59Current $2.59US -----Apr 08, 2011----- Maintained BUY "Best Idea" Target $10.50US IMRS Price day before:$7.82Finish day posting$7.80Current $2.59US --------Jan 19, 2011-------- Maintained BUY Target raised to $9.50 from $9.00US IMRS Price day before:$7.31Finish day posting$7.34Current $2.59US ------Oct 06, 2010----- Maintained BUY Target raised to $8.75 from $8.00US (Target Hit Apr 26, 2011) IMRS Price day before:$5.06Finish day posting$5.28Current $2.59US ****************** Alan Ridgeway Ph.D.....Paradigm….Nov 08, 2011 Target reduced to $6.50 from $8.00US IMRS Price day before:$3.54Finish day posting$3.56Current $2.59US ------Aug 10, 2011------- Target reduced to $8.00 from $9.00US IMRS Price day before:$4.40Finish day posting$3.59Current $2.59US ****************** .....CIBC World Markets….Aug 10, 2011 Target reduced to $7.00 from $10.50US IMRS Price day before:$4.40Finish day posting$3.59Current $2.59US ****************** Cosme Ordonez, MD, PhD.....GMP Securities….Feb 15, 2011 Target raised to $8.50 from $7.00 (Target Hit Apr 26, 2011) IMRS Price day before:$7.59Finish day posting$7.35Current $2.59US Douglas W. Loe, Ph.D.....Versant Partners….Jan 15, 2011 Target $9.75US IMRS Price day before:$7.25Finish day posting$7.31Current $2.59US ****************** Phillip Nalbone.....WedBush….Dec 30, 2010 New OUTPERFORM Target $9.00US IMRS Price day before:$5.50Finish day posting$5.75Current $2.59US ******************
IMRIS Short Positions NSDQ IMRS Current Price $2.59US Date Outstanding Price Range Nov 01 to 15, 2011 $3.76 to $2.29 Oct 16 to 31, 2011 221,682 $3.45 to $3.07 Oct 01 to 15, 2011 225,198 $4.01 to $3.08 Sept 16 to 30, 2011 234,435 $4.65 to $3.60 Sept 01 to 15, 2011 231,028 $4.94 to $3.64 Aug 16 to 31, 2011 192,387 $4.45 to $3.27 Aug 01 to 15, 2011 192,833 $6.78 to $3.55 July 16 to 31, 2011 191,339 $7.29 to $6.25 July 01 to 15, 2011 202,924 $7.41 to $6.57 June 16 to 30, 2011 203,962 $7.14 to $6.12 June 01 to 15, 2011 213,472 $7.58 to $6.67 May 16 to 31, 2011 175,082 $8.20 to $7.14 May 01 to 15, 2011 181,081 $8.82 to $7.01 Apr 16 to 30, 2011 164,224 $8.94 to $7.35 Apr 01 to 15, 2011 161,036 $7.94 to $7.09 Mar 16 to 31, 2011 168,407 $7.50 to $7.17 Mar 01 to 15, 2011 156,624 $7.73 to $7.35
|